for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Geron Corporation

GERN.O

Latest Trade

1.20USD

Change

0.08(+7.14%)

Volume

2,178,769

Today's Range

1.11

 - 

1.20

52 Week Range

1.11

 - 

2.36

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Geron Publishes Analysis Of IMbark Phase 2 In Annals Of Hematology

Oct 11 (Reuters) - Geron Corp <GERN.O>::GERON ANNOUNCES PUBLICATION OF ANALYSES COMPARING REAL WORLD DATA TO IMBARK PHASE 2 IN ANNALS OF HEMATOLOGY.GERON CORP - ANALYSES SUGGEST SURVIVAL BENEFIT ASSOCIATED WITH IMETELSTAT TREATMENT IN COMPARISON TO BEST AVAILABLE THERAPY.GERON CORP - OVERALL SURVIVAL IS PRIMARY ENDPOINT FOR ONGOING PHASE 3 CLINICAL TRIAL IN REFRACTORY MF.

Geron Corporation Reports Greater Than 90% Enrollment In Imerge Phase 3 And Expected Top-Line Results Accelerated To First Quarter Of 2023

Aug 16 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS GREATER THAN 90% ENROLLMENT IN IMERGE PHASE 3 AND EXPECTED TOP-LINE RESULTS ACCELERATED TO FIRST QUARTER OF 2023.Q2 LOSS PER SHARE $0.09.Q2 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES DATA.FINANCIAL RESOURCES, EXPECTED FUTURE NON-DILUTIVE FUNDING UNDER CURRENT DEBT FACILITY, EXPECTED TO FUND OPERATIONS THROUGH END OF Q1 2023.

Geron Posts Q1 Loss Per Share Of $0.09

May 10 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.Q1 LOSS PER SHARE $0.09.Q1 REVENUE $137,000.Q1 REVENUE ESTIMATE $50,000 -- REFINITIV IBES DATA.Q1 EARNINGS PER SHARE ESTIMATE $-0.08 -- REFINITIV IBES DATA.

Geron Corporation Reports Fourth Quarter And Full Year 2020 Financial Results And Operational Highlights

March 11 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS.Q4 LOSS PER SHARE $0.07.Q4 EARNINGS PER SHARE ESTIMATE $-0.07 -- REFINITIV IBES DATA.ENDED YEAR WITH $260 MILLION IN CASH AND MARKETABLE SECURITIES, WHICH IS EXPECTED TO FUND OPERATIONS UNTIL END OF 2022.EXPECT IMERGE PHASE 3 TO BE FULLY ENROLLED IN SECOND HALF OF 2021.DEPENDING ON TIMING OF FULL ENROLLMENT, EXPECT TOP-LINE RESULTS FROM IMERGE PHASE 3 TO BE AVAILABLE FROM END OF 2022 TO H1 2023.FOR IMPACTMF, UNDER CURRENT PLANNING ASSUMPTIONS, WE EXPECT PACE OF ENROLLMENT TO BE SLOWER.GERON - FOR IMPACTMF, UNDER CURRENT ASSUMPTIONS, PROJECT EVENT-DRIVEN ANALYSES FOR TRIAL TO OCCUR IN 2024 FOR INTERIM ANALYSIS, 2025 FOR FINAL.

Geron Corporation Reports Third Quarter 2020 Financial Results And Current Events

Nov 5 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND CURRENT EVENTS.Q3 LOSS PER SHARE $0.06.Q3 REVENUE $108,000.Q3 EARNINGS PER SHARE ESTIMATE $-0.06 -- REFINITIV IBES DATA.Q3 REVENUE ESTIMATE $41,700 -- REFINITIV IBES DATA.2020 FINANCIAL GUIDANCE REAFFIRMED.

Geron Secures Loan Facility For Up To $75 Million

Oct 1 (Reuters) - Geron Corp <GERN.O>::GERON SECURES LOAN FACILITY FOR UP TO $75 MILLION.GERON CORP - ENTERED INTO A LOAN FACILITY FOR UP TO $75 MILLION WITH HERCULES CAPITAL, INC..GERON CORP - RECEIVED $25 MILLION AS PART OF FIRST TRANCHE AT CLOSING, WITH REMAINING $10 MILLION AVAILABLE THROUGH JUNE 15, 2021.GERON CORP - REMAINING $10 MILLION OF FIRST TRANCHE AVAILABLE THROUGH JUNE 15, 2021.GERON CORP - SECOND TRANCHE OF AN ADDITIONAL $15 MILLION IS AVAILABLE TO CO IN 2021.GERON CORP - REMAINING $25 MILLION IN THIRD TRANCHE IS AVAILABLE TO CO THROUGH YEAR-END 2022.

Geron Reports Q2 Loss Per Share Of $0.06

Aug 6 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND CURRENT EVENTS.Q2 LOSS PER SHARE $0.06.Q2 EARNINGS PER SHARE ESTIMATE $-0.06 -- REFINITIV IBES DATA.GERON - CONTINUES TO EXPECT PATIENT ENROLLMENT TO BE COMPLETED BY END OF Q1 OF 2021 ON IMERGE PHASE 3 CLINICAL TRIAL IN MYELODYSPLASTIC SYNDROMES.2020 FINANCIAL GUIDANCE REAFFIRMED.

Geron Posts Q1 Loss Per Share Of $0.08

May 28 (Reuters) - Geron Corp <GERN.O>::ORATION REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.08.Q1 EARNINGS PER SHARE ESTIMATE $-0.12 -- REFINITIV IBES DATA.EXPECTS 2020 OPERATING EXPENSE BURN TO RANGE FROM $70 TO $75 MILLION.GERON - ESTIMATES FINANCIAL RESOURCES PROVIDE SUFFICIENT FUNDS FOR CO'S OPERATIONS INTO SECOND HALF OF 2022.

Geron Corp Announces The Pricing Of Its Public Offering Of Common Stock And Warrants

May 22 (Reuters) - Geron Corp <GERN.O>::GERON CORPORATION ANNOUNCES THE PRICING OF ITS PUBLIC OFFERING OF COMMON STOCK AND WARRANTS.GERON CORP - COMBINED OFFERING PRICE TO PUBLIC OF EACH SHARE OF COMMON STOCK AND ACCOMPANYING WARRANT IS $1.30.GERON CORP - COMBINED OFFERING PRICE TO PUBLIC OF EACH PRE-FUNDED WARRANT AND ACCOMPANYING WARRANT IS $1.299.GERON CORP - INTENDS TO USE NET PROCEEDS FROM THIS PUBLIC OFFERING TO FUND SOME TRIALS.

Geron Corporation Announces Proposed Public Offering Of Common Stock And Warrants

Geron Corp <GERN.O>::GERON CORPORATION ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND WARRANTS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up